Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

Company Presentation - Ginkgo Bioworks CEO Jason Kelly is scheduled to present at the 43rd Annual J P Morgan Healthcare Conference on January 16 2025 at 10 30 a m PT (1 30 p m ET) [1] - Further details webcast link and a replay of the presentation will be posted on the company's investor relations website [1] Company Overview - Ginkgo Bioworks is the leading horizontal platform for cell programming providing flexible end-to-end services across diverse markets including food and agriculture pharmaceuticals and industrial and specialty chemicals [2] - Ginkgo Biosecurity is building next-generation infrastructure and technologies to help global leaders predict detect and respond to biological threats [2] Contact Information - Investor contact email is provided for inquiries [3] - Media contact email is provided for inquiries [3]